Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealth

      Health

      Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
      Health

      Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics

      November 5, 2026
      Pennant Announces Third Quarter 2026 Earnings Release and Call
      Health

      Pennant Announces Third Quarter 2026 Earnings Release and Call

      November 4, 2026
      Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.
      Health

      Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.

      November 3, 2026
      ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
      Health

      ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution

      November 3, 2026
      UPDATE — Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
      Health

      UPDATE — Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

      November 3, 2026
      Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated
      Health

      Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated

      November 3, 2026
      TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
      Health

      TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

      November 2, 2026
      Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
      Health

      Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026

      November 2, 2026
      Regeneron Reports Third Quarter 2026 Financial and Operating Results
      Health

      Regeneron Reports Third Quarter 2026 Financial and Operating Results

      October 30, 2026
      Kestra Medical Technologies to Participate in Upcoming Investor Conferences
      Health

      Kestra Medical Technologies to Participate in Upcoming Investor Conferences

      October 30, 2026
      « 1 2 3 4 5 6 … 226 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026